First test of a potential cheaper copy of a blockbuster drug
NCT ID NCT07334496
Summary
This study aims to see if a new, potentially lower-cost version of the drug dupilumab (Dupixent®) is similar to the original. It will involve 198 healthy Chinese adult men who will receive a single injection and be closely monitored for safety and how the drug moves through their bodies. The goal is to gather initial data to see if the new version behaves like the established drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOSIMILARITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Gobroad Hospital
Beijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.